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Abstract
The effects of ceramides (Cer) on the trafficking of the nicotinic acetylcholine receptor (AChR) to the plasma membrane were studied in CHO-
K1/A5 cells, a clonal cell line that heterologously expresses the adult murine form of the receptor. When cells were incubated with short- (C6-Cer)
or long- (brain-Cer) chain Cer at low concentrations, an increase in the number of cell-surface AChRs was observed concomitant with a decrease
in intracellular receptor levels. The alteration in AChR distribution by low Cer treatment does not appear to be a general mechanism since the
surface expression of the green fluorescent protein derivative of the vesicular stomatitis virus protein (VSVG-GFP) was not affected. High Cer
concentrations caused the opposite effects, decreasing the number of cell-surface AChRs, which exhibited higher affinity for [125I]-α-
bungarotoxin, and increasing the intracellular pool, which colocalized with trans-Golgi/TGN specific markers. The generation of endogenous Cer
by sphingomyelinase treatment also decreased cell-surface AChR levels. These effects do not involve protein kinase Cζ or protein phosphatase 2A
activation. Taken together, the results indicate that Cer modulate trafficking of AChRs to and stability at the cell surface.
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Studies from various laboratories, including ours, have dem-
onstrated the importance of lipids in the homeostasis and ion
channel function of the nicotinic acetylcholine receptor (AChR)
(see reviews in Refs. [1–3]). In particular, sphingolipids (SLs)
and cholesterol (Chol) intervene in the regulation of the traf-
ficking and cell-surface expression of the AChR [3]. Thus, the
decrease in Chol or SL levels induces changes in the dis-
tribution of AChRs, diminishing the number of surface re-
ceptors [4,5] and augmenting their retention at intracellular
compartments [6]. In the case of SLs, it has been demonstrated
that impaired biosynthesis results in lower levels of cell-surfaceAbbreviations: AChR, nicotinic acetylcholine receptor; Cer, ceramides;
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doi:10.1016/j.bbamem.2007.10.019AChR [7], which can be accounted for by the impairment of
AChR assembly and sequestration of unassembled forms in the
endoplasmic reticulum (ER) [8]. The importance of SLs in the
regulation of protein traffic is well documented. In yeast,
alterations in the synthesis of SL result in defects in the trafficking
of the “raft”-resident protein Fus-Mid-GFP from the trans-Golgi
network (TGN) to the plasmamembrane. Newly synthesized cell-
surface proteins have been postulated to travel through compart-
ments containing qualitatively and quantitatively different SLs,
and alteration of their levels could influence protein transport
[9,10]. Until the late 1970s, sphingomyelin (SM) was considered
an inert structural lipid, mainly concentrated in the outer layer of
the plasma membrane. In recent years the emergence of SLs and
other lipids as important secondmessengers has been documented
[11]. Degradation of SM by activation of sphingomyelinase
(SMase) initiates a series of reactions that ends in specific cellular
responses ultimately mediated e.g. by the biosynthetic precursor
of SM, ceramide (Cer). Probable targets for Cer action are Cer-
activated protein phosphatase 2A (PP2A) [12], a Cer-activated
protein kinase [13], the guanine-nucleotide exchange factor Vav
[14] and the protein kinase Cζ (PKCζ) isoform [15–17]. Other
reported effects of Cer are concerned with the promotion of
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Chol have been postulated to occur in laterally segregated lipid
microdomains termed “rafts” [18], suggested to concentrate sig-
naling molecules and receptors in particular regions of the cell
surface [19,20]. Recent studies indicate that Cer are able to
compete with Chol for association with ordered domains in lipid
bilayers [21,22].
In this study we analyzed the effects exerted by Cer on
different properties of the paradigmatic neurotransmitter recep-
tor, AChR, using CHO-K1/A5, a Chinese hamster ovary clonal
cell line developed in our laboratory that stably expresses the
adult form (α2βδɛ) of the murine muscle AChR [7]. Short-
(synthetic C6-Cer) or long- (natural, from bovine brain) chain
Cer at concentrations of 5 μMwere found to increase AChRs at
the cell surface with a concomitant decrease in intracellular
receptor levels. Higher Cer concentrations (25–37.5 μM) caused
the opposite effects. In addition, we observed an increment in the
affinity of the surface AChRs for the specific competitive
antagonist αBTX. Sphingosine, a lipid structurally and meta-
bolically related to Cer, did not produce any significant changes
in surface receptors levels, pointing to the specificity of the effect
exerted by Cer. The endogenous generation of Cer by SMase
treatment also diminished cell-surface AChRs, albeit through a
different mechanism. Taken together, our findings indicate that
the exocytic transport of the AChR can be homeostatically
modulated by Cer which augment or decrease AChR delivery to
the cell surface depending on the Cer concentration.
2. Materials and methods
2.1. Materials
C6-ceramides (C6-Cer) were purchased from Matreya (Pleasant Gap,
Pennsylvania, USA). α-Bungarotoxin (αBTX), D-tubocurarine (d-TC), carba-
moylcholine hydrochloride, nystatin, natural ceramides (from bovine brain,
brain-Cer), sphingosine, sphingomyelinase (SMase) from Bacillus cereus,
okadaic acid, PKCζ pseudo-substrate, mouse monoclonal anti-AChR antibody
mAb 210 and bovine albumin (fraction V, cell culture tested), were from Sigma
Chemical Company (St. Louis, MO, USA). Nutridoma-SP medium with
controlled lipid content was purchased from Boehringer Ingelheim, Germany.
Iodinated α-bungarotoxin ([125I]-αBTX) was purchased from New England
Nuclear (Boston, Mass., USA). Alexa Fluor488-conjugated αBTX (Alexa
Fluor488-αBTX), Alexa Fluor594-αBTX, C6-NBD-ceramide and C5-BODIPY-
SM were from Molecular Probes, OR, USA. The mouse monoclonal anti-
syntaxin 6 antibody was from Stressgen Biotechnologies Corporation, Victoria,
BC, Canada. Alexa Fluor488 F (ab′)2 fragment of goat anti-mouse IgG was from
Molecular Probes, OR, USA. The plasmid coding for the green fluorescence
protein-G-protein of the vesicular stomatitis virus (VSVG-GFP) was a gift from
Dr. Alfonso Gonzalez, Catholic University, Santiago, Chile. The plasmid of the
enhanced yellow fluorescent protein/human β1,4-galactosyltransferase
(pEYFP-Gal-T; Clontech Laboratories Inc., Palo Alto, CA, USA) was a gift
from Drs. Jennifer Lippincott-Schwartz and George Patterson, NIH. The non-
toxic mutant of lysenin conjugated with red fluorescent protein (nt-lysenin-RFP)
was a gift from Dr. T. Kobayashi, RIKEN (Institute of Physical and Chemical
Research), Japan.
2.2. Cell culture
CHO-K1/A5 cells were grown in Ham's F-12 medium supplemented with
glutamine, 40 μg/ml gentamicyn sulphate and 10% bovine fetal serum in a
Napco (model 6100) incubator maintained at 37 °C with a 5% CO2/95% air
mixture. After cells reached 70–80% confluence they were washed and culturedfor an additional period of 30 min and 1, 3 or 5 h under control conditions or in
C6-Cer-, brain-Cer- or sphingosine-supplemented medium. Short- and long-
chain Cer were added as a complex with albumin as reported by Rosenwald and
Pagano [23], whereas sphingosine was solubilized in methanol (solvent
concentration in the culture medium was kept below 0.2%).
2.3. Sphingomyelinase controlled hydrolysis
This series of experiments were carried out on cells cultured as described
above and then subjected to SMase (100 mU/ml) hydrolysis for 1 h at 37 °C in
delipidated medium. In some cases, 10 min incubation with 0.1 μM okadaic acid
or 2.5 μM PKCζ pseudo-substrate preceded the incubation with SMase. For
nystatin treatment, the drug (50 μg/ml) was added in delipidated medium and
incubated at 37 °C for 30 min; cells were further incubated for 1 additional hour
in the absence or presence of SMase, in the continuous presence of nystatin. In
the case of long Cer treatments, CHO-K1/A5 cells were incubated with 5 μM
C6-Cer or brain-Cer for 24 h in Nutridoma-BO medium devoid of serum.
Exogenous SM at a final concentration of 10 μMwas added to cells as described
in a recent work from our laboratory [8] using ethanol:decane (98:2 per vol.) as a
vehicle. The latter was kept below 0.16%.
2.4. Equilibrium and kinetic studies of [125I]-α-bungarotoxin binding
Surface AChR expression was determined by incubating 70–80% confluent
cells with increasing concentrations (5–60 nM) of [125I]-αBTX in cell culture
medium for 1 h at 25 °C. At the end of the incubation period, dishes were
washed twice with Dulbecco's phosphate-buffered saline and the cells were
removed by scraping and collected with 0.1 N NaOH. The radioactivity was
measured in a gamma counter with an efficiency of 80%. Non-specific binding
was determined from the radioactivity remaining in the dishes when the cells
were first pre-incubated with 10 μM native αBTX or 10 mM carbamoylcholine
chloride before addition of [125I]-αBTX. Non-specific binding amounted to 10%
in control and treated cells. The metabolic half-life of surface AChR was
determined as described previously [24]. Cell cultures were labeled with 10 nM
[125I]-αBTX for 1 h at 37 °C, washed twice and incubated for the indicated
periods. Non-specific binding was determined as described above for the
equilibrium experiments. The half-time of degradation was determined from
linear regression analysis of the decay curve. Total AChR was determined after
lysis of the cells in 10 mM Tris HCl buffer, pH 7.4, containing 150 mM NaCl,
5 mM EDTA, 1% Triton X-100, 0.02% NaN3, and 10 μg/ml each chymostatin,
leupeptin, pepstatin, tosyl-lysine chloromethyl ketone and tosyl phenylalanine
chloromethyl ketone, all added to the buffer immediately before use [25]. Cell
extracts were frozen and the binding assay was carried out as described
previously [26]. Briefly, the extracts were thawed and 20–40 μl aliquots of the
cell lysate were incubated with 10 mM phosphate buffer containing 100 mM
NaCl, 1% Triton X-100 and [125I]-αBTX (60 nM) in a final volume of 125 μl. In
these cases, non-specific binding was determined in samples treated with 10 mM
carbamoylcholine chloride, or boiled for 5 min prior to the binding assay. Non-
specific binding obtained by either procedure amounted to 20–30% of the total.
The binding reaction was terminated by the addition of 100 μl of the incubation
reaction on DE-81 paper dishes (Whatman, Germany). DE-81 papers were
washed three times in 10 mM phosphate buffer containing 0.1% Triton X-100 at
10 min intervals. Dried papers were counted in a Beckman gamma counter with
80% efficiency. The internal pool of AChR was calculated as the difference
between the total number of [125I]-αBTX binding sites and cell-surface sites. In
other experiments, total AChR was determined by brief (5 min) treatment of the
cells on the Petri dish with 0.5% saponin in phosphate buffer. The detergent was
removed, the cells washed, and AChR levels determined by the standard [125I]-
αBTX binding assay [6,7]. The rate of αBTX association was calculated by
following the time-dependent formation of [125I]-αBTX–AChR complexes in
cells incubated with radioiodinated toxin (10 nM) for different periods.
2.5. Inhibition of initial rates of αBTX binding
Determination of the IC50 for the full agonist carbamoylcholine was carried
out by measuring the initial rate of [125I]-αBTX binding in the presence of the
agonist. Cells were incubated in 800 μl of culture medium plus 100 μl of the
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[125I]-αBTX was added to the medium at a final concentration of 10 nM and
incubation continued for a further 20 min. The medium was then removed and
the cells were washed with Dulbecco's buffered saline and solubilized by 0.1 N
NaOH.
2.6. Protein content
Protein content was determined by the method of Lowry et al. [27] upon
solubilization of cells with 0.1 NNaOH using bovine serum albumin as standard.
2.7. Lactate dehydrogenase activity
In order to evaluate the occurrence of cell damage at high Cer
concentrations, the activity of lactate dehydrogenase (LDH) released in the
culture medium was determined [28,29] using a UV kinetic assay (Wiener Lab,
Rosario, Argentina) that measures the amount of NADH converted to NAD+.
LDH levels from cells disrupted with an ultrasonic homogenizer were used as a
control of cellular damage.
2.8. Cell transfection
CHO-K1/A5 cells were transiently transfected with the cDNA coding for the
fusion proteins pEYFP-Gal-T and VSVG-GFP using the Polifect transfection
reagent (Quiagen Inc. CA, USA). Transfection was performed 24 h before Cer
treatment.
2.9. Lipid analysis
In some experiments, C6-Cer were added to the culture medium as a
precursor for the synthesis of SM and glucosylceramide (GlcCer). For this
purpose, CHO-K1/A5 cells were cultured in 10 cm culture dishes in the presence
of complete medium for one day. They were subsequently washed with sterile
phosphate-buffered saline (PBS; 150 mM NaCl, 10 mM Na2HPO4, 10 mM
NaH2PO4, pH 7.4) and Nutridoma-BO medium was added. The cells were then
incubated with 5 μM C6-Cer in the presence of trace concentration (25 nM) of
C6-NBD-Cer at 37 °C for 0.5 and 24 additional hours. Lipid extracts were
prepared as previously described [6]. SLs were separated by thin-layer
chromatography using silica gel G plates and CHCl3:CH3OH:H2O, 65:25:4
(by vol.) as the mobile phase [30,31]. C6-NBD-Cer and C5-BODIPY-SM were
used as fluorescent standards. Fluorescent lipid spots were detected by UV
illumination.
2.10. Fluorescence microscopy
In order to label surface AChRs, cells were incubated with Alexa Fluor488-
conjugated αBTX (Alexa Fluor488-αBTX) at a final concentration of 1 μg/ml in
PBS, for 1 h, on ice. Excess label was removed by washing with PBS prior to
microscopy. To label intracellular AChRs, cell-surface AChRs were first
saturated by incubation of CHO-K1/A5 cells with 1 μg/ml native αBTX in PBS
for 1 h. Cells were then fixed with 4% paraformaldehyde for 40 min,
permeabilized with 0.1% Triton X-100 for 20 min, and incubated with Alexa
Fluor594-αBTX at a final concentration of 1 μg/ml for 1 h at room temperature.
For colocalization studies of intracellular AChRs with the TGN marker
syntaxin 6, cells were fixed and permeabilized as above, and incubated with
primary antibody (mouse anti-syntaxin 6, 1:500) for 1 h at room temperature in
PBS containing 1% BSA. Cells were then washed three times with PBS and
incubated with secondary fluorophore-conjugated antibody (Alexa Fluor488-
goat anti-mouse IgG, 1:5000). Alexa Fluor647-αBTX was added with the
secondary antibody to label intracellular AChRs. Incubation was performed at
room temperature for 1 h in PBS containing 1% BSA. Cells were washed three
times with PBS before coverslips were mounted.
Fluorescence imaging was carried out using a wide-field imaging system
(Nikon Eclipse E-600 microscope) accomplished with a SBIG model ST-7
digital charge-coupled device camera (765×510 pixels, 9.0×9.0 μm pixel size,
Santa Barbara, CA), thermostatically cooled at −10 °C. The ST-7 CCD camera
was driven by the CCDOPS software package (SBIG Astronomical Instruments,version 5.02, Santa Barbara, CA). For all experiments a 60× (1.4 N.A.) oil-
immersion objective was used. Appropriate dichroic and emission filters were
employed to avoid crossover of fluorescence emission. Confocal images were
acquired with a Leica TCS SP2 microscope (Leica Microsystems Heidelberg
GmbH).
2.11. Quantitative analysis of fluorescence microscopy images
Fluorescence images were analyzed with the software Scion Image version
4.0.2 (Scion Corp., Frederick,MD). Fluorescence intensities weremeasured in 8-
bit images by selecting small membrane areas (cell-surface AChR) or by
delimiting the whole cell (intracellular AChR). Fluorescence intensity values
were corrected for background fluorescence. The average fluorescence intensity
over distinct areas of the cell surface was calculated for randomly chosen cells for
each experimental condition. For illustration purposes, images were processed
using Adobe Photoshop 5.5, scaled with identical parameters, and pseudo-
colored according to the corresponding emission wavelength.
2.12. Evaluation of unassembled AChR by fluorescence microscopy
Unassembled AChR was determined using a fluorescence microscopy assay
based on agonist inhibition of αBTX binding recently introduced by our
laboratory [8]. Briefly, cell-surface AChRswere blockedwith native toxin, fixed,
permeabilized and incubated with 10 mM carbamoylcholine for 1 h at room
temperature, and subsequently incubated with Alexa594-αBTX in the presence of
agonist. As a control for total intracellular AChR, cells were incubated with PBS
instead of agonist for the same period. Quantitative measurements of
fluorescence intensities of intracellular AChR label in the presence and absence
of agonist provided an estimation of the amount of unassembled AChR.
2.13. AChR internalization studies
Surface AChRs were labeled with Alexa488-αBTX at 4°C as described
above, followed by incubation at 37 °C for increasing periods (from 0 to 4 h) in
the presence or absence of SMase. The fluorescence intensity at the cell surface
and the ratio of surface to total AChR was calculated for each incubation time. In
some cases, a double-labeling protocol was carried out as in Borroni et al. [4].
Cells were first labeled with Alexa647-αBTX (far red) at 4 °C (to arrest receptor
internalization) and then incubated at 37 °C for 0 and 1 h, respectively, to re-
establish endocytic processes. To reveal those AChRs remaining at the cell
surface, cells were then labeled with mAb 210 (which recognizes an
extracellular epitope of the α1 AChR subunit) at 4 °C, and subsequently
labeled with Alexa488-labeled secondary antibody (green).
2.14. Fluorescence microscopy of membrane sheets
For preparation of membrane sheets, CHO-K1/A5 cells were grown on
polylysine-coated glass coverslips and disrupted as described previously [4,5]
using a 300 ms ultrasound-pulse in ice-cold KGlu buffer (20 mMHepes, pH 7.2,
containing 120 mM potassium glutamate and 20 mM potassium acetate). In the
case of SM hydrolysis, membrane sheets were incubated for 30 min at 37 °C in
KGlu buffer containing 100 mU/ml SMase, followed by washing with ice KGlu
buffer. Control sheets were incubated with only KGlu buffer. They were then
double-stained with 1 μg/ml Alexa488-αBTX, and nt-lysenin-RFP for 60 min at
4 °C in KGlu buffer, washed 2–3 times with KGlu buffer, fixed for 30 min in
PBS containing 4% PFA, and washed with PBS. Finally, membrane sheets were
labeled with 25 μl/ml of a saturated TMA-DPH solution in PBS, in order to
identify membrane sheets avoiding preferential selection according to their
staining intensity in the Alexa488-αBTX (green) or in the nt-lysenin-RFP (red)
channel.
2.15. Lysenin labeling of cell-surface SM
The localization and distribution of cell-surface SM of control and SMase-
treated cells were evaluated using lysenin, a fluorescent probe that specifically
binds to SM [32]. We used a non-toxic mutant of lysenin conjugated with red
fluorescent protein (nt-lysenin-RFP) [33]. After 1 h incubation in the presence or
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for 1 h on ice. The fluorescence intensity of lysenin-labeled SM at the cell
surface was quantified by fluorescence microscopy.
2.16. Endogenous generation of C5-BODIPY-Cer
Direct observation of endogenously generated Cer was accomplished using
fluorescence microscopy. First cells were incubated with 15 nM C5-BODIPY-
SM in Ham's F-12 medium devoid of serum for 30 min on ice to label the
plasma membrane of CHO-K1/A5 cells. Upon washing with PBS to removeFig. 1. Incubation with low Cer concentrations increases the number of cell-surface
incubated for 24 h under control conditions (left panel), 5 μMC6-Cer (middle panel) o
B) Fluorescent signal of Alexa Fluor488-αBTX arising from surface AChR of cont
⁎pb0.05. C) Quantification of intracellular receptors labeled with Alexa Fluor594-αB
[125I]-αBTX binding in control CHO-K1/A5 cells (●) and in cells incubated with 5
grown either under control conditions (left panel) or in the presence of 5 μMC6-Cer f
signal at the cell surface. ⁎pb0.01. Scale bar: 10 μm. F) Endogenous generation of flu
with C6-NBD-Cer. CHO-K1/A5 cells were incubated with 5 μM C6-Cer+C6-NBD-
separated by TLC as described in Materials and methods. C5-BODIPY-SM and C6-N
under UV light. G) The increment in cell-surface AChR exerted by 5 μM Cer is not
bars) and unassembled (empty bars) intracellular AChR in control and CHO-K1/A5 c
by preincubation with 10 mM carbamoylcholine before labeling with Alexa Fluor59unbound C5-BODIPY-SM, cells were incubated for 5 min at 37 °C in the
absence or presence of bacterial SMase [34].
2.17. Data analysis
Data obtained from saturation isotherms, as well as the transformed
Scatchard plots, association kinetic, displacement experiments, and half-life of
the cell-surface receptor were analyzed using the Origin 5 software from Origin
Lab Corporation. Statistically significant differences were determined by the
Student's t-test (two-tailed).AChRs with concomitant diminution of the intracellular receptor pool. A) Cells
r 5 μM brain-Cer (right panel) were labeled with Alexa488-αBTX for 1 h at 4 °C.
rol CHO-K1/A5 cells or those treated with 5 μM Cer for 24 h. ⁎⁎pb0.01 and
TX in cells treated with 5 μM C6-Cer. ⁎pb0.05. D) Scatchard plots of specific
μM C6-Cer (○). E) Fluorescence images of VSVG-GFP fluorescence in cells
or 24 h (right panel). Bars represent the quantification of VSVG-GFP fluorescent
orescent SM and glucosylceramide species upon incubation of CHO-K1/A5 cells
Cer for 0.5 h or 24 h. Lipids were extracted and C6-NBD-Cer metabolites were
BD-Cer were used as fluorescent standards. Chromatogram was photographed
due to receptor assembly enhancement. Total (assembled+unassembled=filled
ells treated with 5 μMC6-Cer for 24 h. Unassembled α subunits were determined
4-αBTX. Values are expressed as percentage of total control AChR.
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3.1. Low Cer concentrations increase cell-surface AChR and
reduce the number of intracellular receptors
In order to evaluate whether Cer affect the distribution of the
AChR, CHO-K1/A5 cells (a clonal CHO cell line expressing
the adult form of the AChR) were incubated for 24 h in lipid-
deficient medium (Nutridoma-BO) in the presence of short (C6)
Cer at a final concentration of 5 μM and wide-field fluorescence
microscopy was used to study the distribution of the AChR.
Surface AChRs were labeled with the fluorescent derivative of
αBTX, Alexa Fluor488-αBTX (green), and intracellular recep-
tors were visualized by Alexa Fluor594-αBTX (red) staining.
C6-Cer-treated cells showed a marked (∼50%) increase in cell-
surface Alexa Fluor488-αBTX green fluorescence (Fig. 1A–B),
whereas the intracellular red fluorescence showed a ∼28%
diminution with respect to controls (Fig. 1C).Fig. 2. Distribution of AChR in CHO cells. A) Percentage of cell-surface (empty bar
incubated for 5 h under different experimental conditions. Total receptor corresponds
(or upon saponin permeabilization); the intracellular pool was calculated as the differ
Ham F-12 medium plus bovine serum (control), in serum-free medium plus albumin,
are mean values±SD of five different samples from at least two separate experiments
shown here for the highest concentration of the exogenous lipid. Data shows the perc
control cells (filled bars). C) Cell-surface fluorescence of Alexa Fluor488-αBTX-labe
5 h. ⁎pb0.0001. D) Fluorescence microscopy images of VSVG-GFP expressed in c
Bars represent the quantification of VSVG-GFP fluorescent signal at the cell surfacAlthough short-chain Cer (C2-Cer) are found in nature together
with longN-acyl chain Cer [35], the effects exerted by the former
might differ from those induced by long-chain species (see review
in Ref. [36]).We therefore compared the results obtainedwith C6-
Cer with those produced with the more common and naturally
occurring long-chain Cer, using a complex mixture of long-chain
Cer from bovine brain. As shown in Fig. 1A–B, brain-Cer also
increased (∼42%) surface AChR as assessed by fluorescence
microscopy.
Experiments using [125I]-αBTX were conducted next to
determine whether Cer treatment affected the equilibrium binding
of this competitive antagonist. The Bmax for the cell-surface
AChR obtained from Scatchard analysis was 40% higher in C6-
Cer-treated cells (from 886 fmol/mg protein in control cells
to 1158 fmol/mg protein in Cer-treated cells; Fig. 1D), in
full agreement with the fluorescence microscopy experiments
(Fig. 1A–B). The increment in cell-surface AChR induced by C6-
Cer was not accompanied by changes in the Kdapp for [
125I]-s) and intracellular [125I]-aBTX binding sites (filled bars) in CHO-K1/A5 cells
to [125I]-αBTX binding sites upon detergent solubilization of CHO-K1/A5 cells
ence between the total and cell-surface AChR. Cells were incubated in complete
or in the latter medium supplemented with 12.5, 25, or 37.5 μM of C6-Cer. Data
. B) Time-dependence of C6-Cer inhibition of cell-surface [
125I]-αBTX binding,
entage values obtained after treatment (empty bars) with respect to that found in
led receptors in control and CHO-K1/A5 cells treated with 37.5 μM C6-Cer for
ontrol (left panel) and 37.5 μM C6-Cer-treated (right panel) CHO-K1/A5 cells.
e. Scale bar: 10 μm.
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their affinity, was affected by 24 h Cer treatment (Fig. 1D).
In order to determine whether Cer treatment affected the
trafficking of proteins other than the AChR, CHO-K1/A5 cells
were transfected with the cDNA coding for the vesicular
stomatitis virus G protein-green fluorescent protein VSVG-
GFP. This fluorescent protein is an efficient probe for following
the fate of integralmembrane proteins along the exocytic pathway
[37]. Transfected CHO-K1/A5 cells were subsequently incubated
with 5 μMC6-Cer and the surface expression of VSVG-GFP was
quantified. We observed no significant differences between the
surface fluorescent signal of VSVG-GFP of control and Cer-
treated cells, indicating that the alteration in the AChR traffic by
low Cer treatment was not a general mechanism (Fig. 1E).
In order to identify the lipid species generated upon 24 h
incubation with 5 μM C6-Cer in the presence of trace con-
centrations of C6-NBD-Cer, cells were submitted to Folch lipid
extraction and subsequent TLC separation with the solvent
system described by Lipsky and Pagano [30]. After 0.5 h in-
cubation, C6-NBD-SM was observed in the thin-layer chroma-
tograms. However, the fluorescent spot corresponding to C6-
NBD-Cer was still present. After 24 h incubation, C6-NBD-SM
and C6-NBD-GlcCer fluorescent bands could be visualized,
whereas the C6-NBD-Cer were no longer present (Fig. 1F).
As recently reported by Baier and Barrantes [8] the addition
of exogenous SM to the culture medium of CHO-K1/A5 cellsFig. 3. Pharmacological characterization of AChR from control and C6-Cer-treated
αBTX in control (●) and CHO-K1/A5 cells incubated in the presence of 25 μM o
C) Displacement curves of the total radioactive αBTX binding promoted by the pre
incubated with 37.5 μM C6-Cer. D) Association kinetics of αBTX to AChR for botcaused a 3-fold increase in the number of AChRs present at the
plasma membrane (data not shown).
3.2. The increase in cell-surface AChR by 5 μM Cer does not
involve enhanced receptor assembly
In order to determine whether the augmented cell-surface
AChR levels were due to enhanced AChR assembly after a long
period (24 h) of Cer incubation, unassembled receptors were
measured next using a fluorescence microscopy assay recently
introduced by our laboratory [8]. In control cells the percentage
of unassembled α subunits was∼40%, diminishing to∼30% in
Cer-treated cells (Fig. 1G). Since the total amount of intra-
cellular AChR in Cer-treated cells is lower, as judged by the
fainter intensity of the fluorescence signal (Fig. 1C) (which
corresponds to the sum of assembled+unassembled intracel-
lular AChRs, Fig. 1G) the ratio of total/unassembled AChR in
Cer-treated cells did not differ from the control cells.
3.3. Treatment with high short-chain ceramide (C6-Cer)
concentrations decreases cell-surface AChR and increases the
intracellular receptor pool
We next evaluated the effects of increasing Cer concentra-
tions on AChR distribution. Exposure of CHO-K1/A5 cells for
periods of up to 5 h with concentrations of C6-Cer of 12.5 μMcells. A–B) Scatchard plots obtained with the specific binding of radioiodinated
f C6-Cer (○) (A) and those incubated under control and 37.5 μM C6-Cer (B).
sence of the indicated carbamoylcholine concentrations from control and cells
h of the later conditions. Inset: linearization of the association curves in (D).
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αBTX (Fig. 2A). However, incubations with 25 and 37.5 μM
C6-Cer resulted in a decrease in cell-surface AChR with a
concomitant increase in the intracellular AChR pools (Fig. 2A),
without significant changes in the total amount of AChR. This
effect was time-dependent (Fig. 2B); cell-surface AChR de-
creased to 77±7 and 54±11% of control values at 3 and 5 h,
respectively. Since short-chain Cer have been postulated to
produce damage in some cell systems [38], a series of ex-
periments were carried out to evaluate this possibility using a
well known test, the assay of the cytosolic enzyme LDH [28,29].
No significant differences were detected in LDH levels between
control cells and cells incubated with 37.5 μM of C6-Cer for 3
and 5 h at 37 °C (Supplementary Fig. 1).
Fluorescence microscopy experiments were performed in
parallel to study the distribution of AChR in Cer-treated CHO-
K1/A5 cells. A 46% reduction in cell-surface Alexa Fluor488-
αBTX fluorescence was observed in cells treated with 37.5 μM
C6-Cer with respect to controls (Fig. 2C). The surface ex-
pression of the fusion protein VSVG-GFP was also significantly
reduced (∼45%) by this treatment (Fig. 2D) indicating that Cer
treatment at high concentrations affected the traffic of other
proteins besides the AChR.
We next evaluated whether high Cer concentration affected
the affinity of the AChR–αBTX complex formation. C6-Cer
produced an increase in [125I]-αBTX affinity for the AChR in
addition to a reduction in the density of cell-surface receptor
(Fig. 3A–B). The higher affinity of the AChR upon Cer treat-Fig. 4. High C6-Cer concentrations increase the intracellular pool of AChR and chan
with Alexa Fluor594-αBTX in CHO-K1/A5 cells incubated under control conditions
intracellular Alexa Fluor647-αBTX-labeled-receptors (left panel) with the trans-Go
37.5 μM Cer-treated cells. Merged images are given in the right panel. Scale bar: 10
(left panel) with syntaxin 6 (middle panel) in cells treated with 5 μM Cer. Right panment was also apparent in competition experiments using the
full agonist carbamoylcholine (Fig. 3C). The apparent equili-
brium dissociation constant of those AChRs remaining at the
cell surface upon Cer treatment decreased by ∼50% and ∼60%
in cells treated with 25 and 37.5 μM C6-Cer, respectively. This
change in affinity could be accounted for by the corresponding
changes in the kinetics of [125I]-αBTX binding to cell-surface
AChR, which also showed statistically significant differences
between Cer-treated and control cells. As shown in Fig. 3D, the
rate of association between toxin and AChR increased upon Cer
treatment. Thus, the decrease in cell-surface AChR levels can-
not be accounted for by a decrease in affinity for the competitive
antagonist αBTX.
3.4. C6-Cer treatment arrests AChR at the exiting end of the
Golgi complex
Treatment with 37.5 μMC6-Cer for 5 h increased intracellular
Alexa Fluor594-αBTX fluorescence by ∼50% (Fig. 4A). The
pattern of intracellular fluorescence also changed: whereas in
control cells the AChR was quite uniformly distributed over the
entire cell, a higher fluorescence intensity was observed at the
perinuclear region in cells treated with C6-Cer (Fig. 4B). Since
this pattern was reminiscent of the trans-Golgi network (TGN),
identified in a previous work from our laboratory as the sub-
cellular compartment where AChR is arrested upon impairment
of Chol biosynthesis [6], cells were also transiently transfected
with the pEYFP-Golgi vector, which codifies for the fusionge its intracellular distribution. A) Percentage of intracellular receptors labeled
or in the presence of 37.5 μM C6-Cer for 5 h. ⁎pb0.001. B) Colocalization of
lgi/TGN markers pEYFP-Gal-T and syntaxin 6 (middle panel) in control and
μm. C) Colocalization of intracellular Alexa Fluor647-αBTX-labeled-receptors
el: merged images. Scale bar: 10 μm.
Fig. 5. Brain-Cer affect the AChR distribution in CHO-K1/A5 cells. Cells were
grown either in control medium or in the presence of 37.5 μM brain-Cer for 5 h.
A) Fluorescence microscopy images of surface receptors labeled with Alexa
Fluor488-αBTX in control (left panel) and Cer-treated cells (right panel). Scale
bar: 10 μm. B) Percentage of Alexa Fluor488-αBTX fluorescent signal at the cell
surface. ⁎pb0.001. C) Histograms quantifying intracellular receptors labeled
with Alexa Fluor594-αBTX. Fluorescence was quantified as described in
Materials and methods. ⁎pb0.0001.
924 C.E. Gallegos et al. / Biochimica et Biophysica Acta 1778 (2008) 917–930protein pEYFP-Gal-T. Gal-T is a well knownmarker of the TGN
[39,40]. Twenty-four hours after transfection the cells were
incubated with 37.5 μMC6-Cer for 5 h and intracellular AChRs
were labeled with Alexa Fluor647-αBTX. Confocal microscopy
images revealed an important degree of colocalization of the
fluorescent signals arising from intracellular-labeled AChRs and
the TGNmarker (Fig. 4B). As a specific marker of the TGN [41],
the anti-syntaxin 6 antibody yielded similar colocalization with
AChRs (Fig. 4B). Thus, treatment with high C6-Cer concentra-
tions appears to block trafficking of the AChR to the cell surface
and result in the accumulation of the AChR at the exiting end of
the Golgi complex. On the other hand, incubation with low C6-
Cer concentrations (5 μM) did not induce any changes in the
intracellular distribution of the AChR nor in the structure of the
TGN as evaluated by anti-syntaxin 6 labeling (Fig. 4C).
3.5. Long-chain Cer mimic the effect of short-chain Cer on
AChR distribution whereas sphingosine does not
Binding experiments with [125I]-αBTX were carried out to test
the effect of long-chain Cer on AChR distribution. After 5 h
treatment long-chain brain-Cer (37.5 μM) were also found to
reduce surfaceAChRand increase intracellular receptors (Table 1).
A similar reduction of cell-surfaceAChR (∼40%)was observed in
Alexa Fluor488-αBTX fluorescence microscopy experiments
(Fig. 5A–B), with a concomitant increase in intracellular Alexa
Fluor594-αBTX fluorescence (Fig. 5C).
Since Cer can be rapidly converted to sphingosine [42], it
was necessary to confirm that it was Cer and not sphingosine
which exerts the cellular effect. For this purpose we evaluated
whether sphingosine produced changes in AChR distribution
analogous to those detected with Cer. Under conditions similar
to those used for Cer experiments, sphingosine did not affect
surface or intracellular AChR (Table 2).
3.6. Endogenously generated Cer also diminish cell-surface
AChR levels
We next asked the question whether endogenous generation
of Cer affects surface expression of the AChR. For this purpose
CHO-K1/A5 cells were incubated with 100 mU/ml of bacterial
SMase for 1 h at 37 °C. [125I]-αBTX binding assays showed
that cell-surface AChR decreased by ∼35% in SMase-treated
cells (Fig. 6A). Similar results were obtained using the Alexa
Fluor488-αBTX fluorescence microscopy assay (Fig. 6B).Table 1
Effects of brain-Cer on the surface, intracellular and total AChR in CHO-K1/A5
cells
Condition Surface Intracellular Total
Control (6) 527±27 571±140 1098±285
Albumin 3 h (5) 524±4 579±104 1103±199
Brain-Cer 3 h (5) 369±45⁎⁎ 629±159 998±252
Albumin 5 h (7) 532±80 577±115 1109±167
Brain-Cer 5 h (7) 285±106⁎⁎ 462±95 747±154⁎
Results are mean values±SD expressed as fmol of [125I]-αBTX specifically
bound/mg protein. Numbers between parentheses are the number of individual
samples analyzed. ⁎pb0.025; ⁎⁎pb0.001.Since Cer have been implicated in the activation of PP2A
[12,43], and subunit assembly, insertion and stability of the
AChR at the cell membrane have been reported to be affected
by the state of receptor phosphorylation [44–47], we studied
next whether PP2A was involved in the retention of AChR at
intracellular compartments. Incubation with 0.1 μM okadaic
acid, a well known inhibitor of the Cer-activated PP2A [48], did
not reverse the diminution in AChR surface fluorescence signal
produced by SMase treatment (Supplementary Fig. 2).
The ζ isoform of the enzyme protein kinase C (PKCζ) has
also been reported to be activated by Cer [49]. To analyze the
possibility that PKCζwas involved in the Cer-induced alteration
of AChR traffic, the specific inhibitor PKCζ pseudo-substrate
was tested. Similar to what was observed with okadaic acid, this
inhibitor was not able to revert the effects of SMase treatment on
surface AChR levels (data not shown).
An independent assay of SMase action exploited the fluo-
rescent dye nt-lysenin-RFP. Lysenin is an earthworm toxin that
specifically recognizes SM-rich membrane domains and in-
duces cytolysis by pore formation [50]. The specific binding ofTable 2
Effects of sphingosine on the surface and intracellular AChR expressed in CHO-
K1/A5 cells
Condition Surface Intracellular Total
Control (6) 527±27 571±140 1208±121
MeOH 5 h (13) 550±33 549±11 1099±22
Sphingosine 5 h (12) 511±66 619±92 1130±170
Results are mean values±SD expressed as fmol/mg protein. The effect of
sphingosine was determined after 5 h treatment with 37.5 μM SM. Other details
are as in Table 1.
Fig. 6. Endogenous generation of Cer also decreases surface AChR. A) Percentage of cell-surface [125I]-αBTX binding sites in CHO-K1/A5 cells incubated for 1 h
either under control conditions or in the presence of SMase 100 mU/ml. ⁎pb0.005. B) Cell-surface fluorescence of Alexa488-αBTX-labeled receptors in control (left
panel) and SMase-treated (right panel) cells. Scale bar: 10 μm. C) Plasma membrane SM labeled with the fluorescent dye nt-lysenin-RFP in control and SMase-treated
cells. ⁎pb0.0001. Scale bar: 10 μm. D) Fluorescence microscopy images of control and SMase-treated membrane sheets obtained as described in Materials and
methods, and labeled with TMA-DPH (left panel), Alexa488-αBTX (middle panel) and nt-lysenin-RFP (right panel). Scale bar: 5 μm. The perimeter of the membrane
sheets is outlined in the nt-lysenin-RFP panels to facilitate visualization. E) Percentage of Alexa488-αBTX (filled bars) and nt-lysenin-RFP (empty bars) fluorescence
in membrane sheets incubated in the absence (control) or in the presence of bacterial SMase. ⁎pb0.001.
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Fig. 7. Cell-surface AChR diminution in SMase-treated cells is due to an enhanced
internalization. A) Fluorescence microscopy images following the internalization
of plasma membrane AChR labeled with Alexa647-αBTX in control and SMase-
treated cells for the indicated times. Scale bar: 10 μm. B) Curves showing the
decrease in Alexa488-αBTX intensity of cell-surface labeled AChRs as a function
of time for control (●) and SMase-treated cells (○). Inset: Internalization kinetics
of AChR for the experimental conditions described in (B).
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distribution of SM [32]. Here we used the red fluorescent pro-
tein adduct of a non-toxic mutant of lysenin, recently developed
by Kiyokawa et al. [33]. Only discrete puncta remained at the
cell surface after SMase action (Fig. 6C), which reduced the
lysenin fluorescence signal by ∼55% (Fig. 6C).
In order to visualize the endogenous generation of Cer, cells
were labeled with a SM probe, C5-BODIPY-SM, and subjected
to SMase treatment [34]. Upon incubation with SMase for 5 min
at 37 °C, a significant fraction of the fluorescent adduct, C5-
BODIPY-Cer, appeared to have been translocated to the Golgi
region (Supplementary Fig. 3), in agreement with the results of
Pagano et al. [51].
To determine whether the decrease in cell-surface AChR
mediated by SMase treatment was a result of the mere physical
presence (or absence) of the lipid in the membrane, another series
of experiments was conducted on isolated, single-sheets of
AChR-containing plasma membranes, exploiting the formation
of single-sheets of plasma membranes by ultrasound treatment as
recently described in work from our laboratory [4,5]. This treat-
ment results in the “unroofing” of the cells, leaving behind only
their glass-adhered, ventral membrane, and eliminates cytosol,
organelles and metabolic integrity of the cell. Upon incubation of
membrane sheets with SMase for 30 min at 37 °C in KGlu buffer,
the specimens were double labeled with Alexa Fluor488-αBTX
and nt-lysenin-RFP. TMA-DPH labeling was also performed in
order to identify membrane sheets avoiding preferential selection
according to their staining intensity in the Alexa488-αBTX or in
the nt-lysenin-RFP channel. Whereas no significant differences
were observed in the fluorescence signal arising from Alexa
Fluor488-αBTX-labeled receptors, a drastic decrease (∼90%) in
the lysenin fluorescence was apparent (Fig. 6D), suggesting the
possibility that the diminution of AChR levels upon SMase
treatment requires the integrity of the cell.
3.7. The mechanism of cell-surface AChR diminution in
SMase-treated cells is different from that in Cer-treated cells
We have recently reported that Chol depletion by methyl-β-
cyclodextrin causes rapid internalization of the AChR in CHO-
K1/A5 cells [4]. Since Chol and SM are found in close as-
sociation in biomembranes, forming microdomains [18,52], the
decrease in cell-surface AChR upon SMase treatment observed
here could operate through a similar mechanism. To test this
hypothesis we assayed the rate of AChR internalization upon
SMase-mediated cell-surface SM depletion using a double-
labeling protocol as in Ref. [4]: cells were first labeled with
Alexa647-αBTX (far red) at 4 °C and then incubated with
SMase at 37 °C for 0 and 1 h, respectively. AChRs remaining at
the cell surface after these two periods were then labeled with
mAb 210 (which recognizes an extracellular epitope of the α
AChR subunit) at 4 °C, followed by incubation with Alexa488-
labeled secondary antibody (green). In control cells, the signal
associated with the AChR was observed almost exclusively at
the cell surface, in the form of patchy, spotted fluorescence
(Fig. 7). This is due to the aggregation of AChR molecules
effected by cross-linking with the bifunctional mAb IgG (see alsoRef. [5]). Comparison of control conditions at t=0 and t=1 h
revealed an increase in the overlap of fluorescence signals from
“old” (red) and “newly-labeled” (green) AChRs, indicating that a
large proportion of AChRs remained at the cell surface after 1 h
incubation (Fig. 7A). Only few endocytic vesicles (red) could be
seen inside cells after 1 h. In contrast, in SMase-treated cells the
fluorescence accumulated in abundant single-colored endocytic
vesicles (red) concomitantly with a diminution of the overlap
between old and new receptors at the cell surface (Fig. 7A and see
Ref. [4]). In order to determine the kinetics of this process, surface
AChRs were first labeled with Alexa488-αBTX (green) at 4 °C,
followed by incubation with SMase at 37 °C for increasing time
periods (from 0 to 4 h). The fluorescence intensity at the cell-
surface was measured and the ratio of surface/total AChR was
calculated from the time-course of the experiment. The t1/2 was
found to decrease from 1.7 h in control cells to 1 h in SMase-
treated cells (Fig. 7B), indicating that SM depletion by bacterial
SMase accelerated AChR internalization kinetics, roughly to the
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Chol depletion [4].
3.8. Preincubation with nystatin enhanced the reduction in
cell-surface AChR levels induced by SMase
In addition to SM hydrolysis, SMase treatment is reported
to produce the rapid internalization of cell-surface Chol
[53,54,22]. The possibility that the diminution in plasma mem-
brane AChR by SMase was due to Chol internalization rather to
SM depletion was therefore tested. For this purpose we in-
cubated the cells with the sterol-binding antibiotic nystatin,
which specifically interacts with and sequesters the plasma
membrane Chol retained at the membrane [55]. Surface AChR
levels decreased by ∼30% upon nystatin treatment, similar to
the extent observed in SMase-treated cells. When cells were
incubated in the presence of both drugs, a further diminution
(50%) in surface AChR levels resulted (Supplementary Fig. 4),
indicating that SMase itself was effective in decreasing plasma
membrane AChR even though Chol was not being internalized.
4. Discussion
Cer, intermediate molecules in the metabolism of sphingoli-
pids, play an important role as second messengers for many
cellular functions [56,36]. Cer associate with lipid “rafts” [57,58]
and these Cer-enriched microdomains have been reported to
spontaneously fuse into larger Cer-enriched membrane platforms
[59–61]. Through these processes Cer appear to “catalyze”
various signal transduction pathways recruiting membrane
receptors and intracellular signaling molecules.
In the present study we examined the effects of short- and
long-chain Cer on the AChR trafficking to the plasma mem-
brane in a mammalian heterologous expression system, the
CHO-K1/A5 cells. Most natural Cer have a long (16–24 C
atoms) N-acyl chains, but short N-acyl chain Cer (2 C atoms)
also occur in nature [35]. We found that low concentrations of
exogenous C6- or brain-Cer augmented the number of AChRs at
the plasma membrane and decreased receptor levels at intra-
cellular compartments (Fig. 1A–C). Recently Baier and Bar-
rantes [8] showed that SLs are necessary for AChR assembly
and trafficking to the plasma membrane in CHO-K1/A5 cells.
Cer are key lipids in the metabolism of SLs. After a 2 h
incubation of HL-60 cells with long-chain [14C] C16-Cer, most
of the cell-bound radioactivity was found in free Cer and SM
was the major metabolized SL containing labeled Cer [62].
Similar results were reported by Ridgway and Merrian [63] and
Furuya et al. [64] using radiolabeled Cer that were converted
into SM and GlcCer in CHO cells and in cerebellar neurons,
respectively. Here, after 30 min incubation of CHO-K1/A5 cells
with 5 μM C6-Cer in the presence of trace concentrations of C6-
NBD-Cer, the production of C6-NBD-SM was clearly observed
(Fig. 1E). After 24 h incubation, the fluorescent Cer were
completely converted to complex SL. Although the synthesis of
complex SLs was tested only for C6-Cer, long-chain Cer would
be expected to behave similarly in the SL biosynthetic pathway
[65]. Thus, low Cer treatment could contribute to augmentingthe number of AChRs by an indirect mechanism, i.e. by en-
hancing the synthesis of SLs. We have recently demonstrated
that the latter lipids play an important role in the regulation of
AChR exocytic trafficking [8] and that addition of exogenous
SMs results in increased levels of AChR at the cell surface [8].
The alteration in AChR distribution after low Cer treatment
does not appear to be a general mechanism (Fig. 1D). Further-
more, the increment in cell-surface AChR levels produced by
low Cer concentrations without changes in the surface levels of
a predominantly “non-raft” membrane protein like VSVG-GFP
[66] reinforces the importance of SLs for the correct trafficking
of the AChR to the plasma membrane as recently proposed by
Baier and Barrantes [8], and suggests the association of the
AChR with lipid domains along the exocytic pathway.
The effect of higher Cer concentrations was also tested in the
concentration range (between 25 and 37.5 μM) usually em-
ployed to study Cer effects on protein trafficking [23,67]. In this
range, Cer markedly and specifically decreased the number of
AChRs present at the plasma membrane with a concomitant
increase in the intracellular receptor pool. Incubation of CHO-
K1 cells (the cell line progenitor of the one used in the present
study, CHO-K1/A5) with 25 μMC6-Cer is reported to block the
movement of VSVG through the medial- and trans-Golgi ap-
paratus and its subsequent transport to the cell surface [23].
Short-chain Cer were reported to jam the transport of the
scavenger receptor CD36 to the plasma membrane of mono-
cytes and macrophages [67]. Analogously, high Cer concentra-
tions could reduce cell-surface AChRs by blocking the exocytic
traffic of newly synthesized receptors, as suggested by the
changes in intracellular receptor distribution and its accumula-
tion at the perinuclear region (Fig. 4B). More specifically,
pEYFP-Gal-T and syntaxin 6, bona fide markers for the trans-
Golgi/TGN [40,41], colocalized with Alexa Fluor647-αBTX-
labeled-AChR in large vesicular bodies generated by Cer
treatment (Fig. 4B), reminiscent of the multivesicular bodies
that Rosenwald and Pagano [23] characterized by electron
microscopy. Exogenously added short-chain Cer are rapidly
incorporated into cells and accumulate in the Golgi apparatus
[30]. In CHO cells C2-Cer decreased ARF-1 and PKC-α
binding to Golgi-enriched membranes thereby preventing
COP1 transport vesicle formation [68]. It was therefore possible
that the blockade of AChR transport by exogenous Cer could
affect in a more general manner the trafficking of proteins other
than the AChR. This possibility was checked by transfecting
CHO-K1/A5 cells with the fluorescent protein VSVG-GFP. We
observed a significant (∼45%) decrease in the GFP-fluores-
cence signal at the plasma membrane upon treatment with high
C6-Cer concentrations (Fig. 2D), indicating that a more general
blockage of trafficking is operative at high Cer concentrations.
Besides the reduction in the AChR present at the plasma
membrane, incubation with high C6-Cer concentrations caused
an increment in the affinity of the receptor for its canonical
ligand, αBTX (Fig. 3A–D). Förster-type resonance energy
transfer (FRET) studies from our laboratory showed that SMase
digestion of Torpedo AChR-rich membranes generates Cer
species with higher affinity for the receptor than the parental SM
[69]. The increment in receptor affinity for the competitive
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from changes in the biophysical properties of the cell membrane
upon Cer treatment. Heron et al. [70] found that the increment in
the microviscosity of the membranes resulted in an increment in
the Kd of the serotonin receptor for its ligand. Long-chain Cer
have been shown to increase lipid order in model membranes
containing Chol [71]. In contrast, C2- and C6-Cer cause a
concentration-dependent decrease in lipid order as measured by
anisotropy of DPH-PC in plasma membrane vesicles isolated
from RBL-2H3 mast cells [72].
Treatment of CHO-K1/A5 cells with SMase, which hydro-
lyzes plasma membrane SM with generation of endogenous Cer,
also decreased cell-surface AChR levels and accelerated receptor
endocytosis. This is in agreement with the reported reduction in
CD36 expression resulting from SMase action on monocytes and
macrophages [67]. In macrophages and fibroblasts SMase treat-
ment induces formation of numerous vesicles that pinch off from
the plasma membrane and internalize [34]. Acute Chol depletion
from CHO-K1/A5 cells by methyl-β-cyclodextrin treatment
dramatically accelerates AChR endocytosis [4]. The acceleration
of the internalization kinetics by SMase is very similar to that
resulting fromChol depletion by cyclodextrin [4], suggesting that
both may result from a common disruption of Chol/SM-rich lipid
domains. In the case of SMase action, this could produce the
displacement of SM from such lipid domains by virtue of the
higher affinity of the generated Cer for the AChR [69]. Long-
chain Cer have the capacity to specifically displace sterol from
lipid domains [22] and have been shown to require an N-linked
acyl chain with at least 8 methylene units to displace Chol from
SM-rich domains [73]. Interestingly, cell-surface Chol is rapidly
internalized upon SMase action [53,54,22].
The possible synergism between SM and Chol in maintain-
ing AChR cell-surface levels was further suggested by the
nystatin experiments. Treatment with this sterol-binding anti-
biotic (which sequesters membrane-bound Chol but does not
remove it from the plasma membrane, Supplementary Fig. 4),
decreased AChR levels by ∼30%. Preincubation with nystatin
followed by SMase treatment in the continuous presence of
the antibiotic showed a further diminution (∼50%) in surface
AChR levels, indicating that SMase was effective in decreasing
plasma membrane AChR and suggesting that in addition to the
key role played by Chol levels [4,5], SM is also involved in the
stability of the plasma membrane-associated AChR. In sum-
mary, our results show that Cer were effective in modulating the
trafficking of the AChR expressed in CHO-K1/A5 cells and that
they exerted these effects in opposite ways and through different
mechanisms depending on the lipid concentration.
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